Efficacy of BIBF 1120 or BIBF 1120 plus chemotherapy on nasopharyngeal carcinoma in vitro and in vivo

PURPOSE: BIBF 1120 is a potent triple angiokinase inhibitor now being evaluated in many types of tumors. We examine the antitumor effects of BIBF 1120 on nasopharyngeal carcinoma (NPC) in vitro and in vivo. MATERIALS AND METHODS: The effect of BIBF 1120 on NPC cell proliferation was evaluated using...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug Des Devel Ther
Hauptverfasser: Xue, Cong, Tian, Ying, Zhang, Jing, Zhao, Yuanyuan, Zhan, Jianhua, Fang, Wenfeng, Zhang, Li
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2016
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4801128/
https://ncbi.nlm.nih.gov/pubmed/27042009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S96634
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge